Enhanced Healthcare Partners has held a final closing of Enhanced Healthcare Partners LP with $300 million of committed capital.
The new fund will make minority and majority investments in founder and entrepreneur-led lower middle-market healthcare businesses with specific interest in physician services, pharma services, payor services, and healthcare technology sectors. Typical targets will be based in North American and have from $50 million to $250 million in enterprise value.
Enhanced Healthcare Partners (EHP) is based in New York and is led by Managing Partner Malcolm Kostuchenko, Managing Partner Samarth Chandra and Partner Matthew Thompson.
“We are thankful for the support from our limited partners,” said Mr. Kostuchenko. “This closing represents an exciting chapter for the EHP team as we continue to drive a thesis-oriented healthcare investment strategy in the lower middle-market with the ability to focus on building value over the long term consistent with our overall approach and strategy.”
“We are grateful for the opportunity to continue to build on EHP’s track record,” said Matthew Thompson, a partner at EHP. “We have the honor of partnering with an extraordinary set of advisors, board members and experts to develop innovative approaches to value creation. This new fund enables us to take our investment strategy to the next level.”
EHP is advised by Andrew Paul, the founder of Enhanced Equity. The raising of the new fund represents the next chapter for EHP after the team completed a recapitalization of Enhanced Equity’s eight healthcare assets in 2017. “I am proud of the EHP team and excited to support them in this next phase. EHP will continue to build on the strategy we started at Enhanced Equity,” said Mr. Paul.
Kirkland and Ellis provided legal services to EHP on this fundraise.
© 2019 Private Equity Professional | September 25, 2019